Literature DB >> 23083892

Hepatitis C virus-host interactions, replication, and viral assembly.

Ana Shulla1, Glenn Randall.   

Abstract

As a relatively simple virus, hepatitis C virus (HCV) depends extensively on its host to infect, replicate and disseminate. HCV has evolved host interactions that result in a restricted tropism, both in terms of cell type and species. Efforts into identifying and validating HCV-host interactions have been hampered by a limited number of infectious virus clones and cell lines that support HCV infection. Despite these limitations, consensus HCV-host interactions have emerged that help define the entry, replication, assembly, and tropism of HCV. This has had important implications in expanding our in vitro and in vivo systems to study HCV replication and pathogenesis. Additionally, a number of these host factors are being targeted for therapeutic development. In this review, we focus on medically relevant pro-viral host factors, their role in HCV biology, and their importance in expanding our model systems.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23083892      PMCID: PMC3508086          DOI: 10.1016/j.coviro.2012.09.013

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  111 in total

1.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

2.  Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.

Authors:  Carolyn B Coyne; Jeffrey M Bergelson
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

3.  Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Authors:  Emmanuelle Blanchard; Sandrine Belouzard; Lucie Goueslain; Takaji Wakita; Jean Dubuisson; Czeslaw Wychowski; Yves Rouillé
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Treating viral hepatitis C: efficacy, side effects, and complications.

Authors:  M P Manns; H Wedemeyer; M Cornberg
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 5.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

6.  Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.

Authors:  Shufeng Liu; Wei Yang; Le Shen; Jerrold R Turner; Carolyn B Coyne; Tianyi Wang
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

7.  Replication of a hepatitis C virus replicon clone in mouse cells.

Authors:  Susan L Uprichard; Josan Chung; Francis V Chisari; Takaji Wakita
Journal:  Virol J       Date:  2006-10-28       Impact factor: 4.099

8.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

9.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  microRNA-122 stimulates translation of hepatitis C virus RNA.

Authors:  Jura Inga Henke; Dagmar Goergen; Junfeng Zheng; Yutong Song; Christian G Schüttler; Carmen Fehr; Christiane Jünemann; Michael Niepmann
Journal:  EMBO J       Date:  2008-11-20       Impact factor: 11.598

View more
  27 in total

Review 1.  Zoonotic Potential of Simian Arteriviruses.

Authors:  Adam L Bailey; Michael Lauck; Samuel D Sibley; Thomas C Friedrich; Jens H Kuhn; Nelson B Freimer; Anna J Jasinska; Jane E Phillips-Conroy; Clifford J Jolly; Preston A Marx; Cristian Apetrei; Jeffrey Rogers; Tony L Goldberg; David H O'Connor
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

Review 2.  Bioreactor technologies to support liver function in vitro.

Authors:  Mohammad R Ebrahimkhani; Jaclyn A Shepard Neiman; Micha Sam B Raredon; David J Hughes; Linda G Griffith
Journal:  Adv Drug Deliv Rev       Date:  2014-03-05       Impact factor: 15.470

Review 3.  Hepatitis C.

Authors:  Daniel P Webster; Paul Klenerman; Geoffrey M Dusheiko
Journal:  Lancet       Date:  2015-02-14       Impact factor: 79.321

4.  Inhibition of hepatitis C virus genotype 4 replication using siRNA targeted to the viral core region and the CD81 cellular receptor.

Authors:  Reem M Aljowaie; Fahad N Almajhdi; Hebatallh H Ali; Mohammad S El-Wetidy; Medhat K Shier
Journal:  Cell Stress Chaperones       Date:  2020-02-14       Impact factor: 3.667

Review 5.  Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.

Authors:  Troels K H Scheel; Charles M Rice
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

6.  KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development.

Authors:  Orit Goldman; Songyan Han; Marion Sourisseau; Marion Sourrisseau; Noelle Dziedzic; Wissam Hamou; Barbara Corneo; Sunita D'Souza; Thomas Sato; Darrell N Kotton; Karl-Dimiter Bissig; Tamara Kalir; Adam Jacobs; Todd Evans; Matthew J Evans; Valerie Gouon-Evans
Journal:  Cell Stem Cell       Date:  2013-06-06       Impact factor: 24.633

7.  Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection.

Authors:  Martina Friesland; Lidia Mingorance; Josan Chung; Francis V Chisari; Pablo Gastaminza
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

8.  Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.

Authors:  Ana M Chamoun-Emanuelli; Eve-Isabelle Pecheur; Rudo L Simeon; Da Huang; Paul S Cremer; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

9.  N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.

Authors:  Cameron J Schweitzer; Fang Zhang; Audrey Boyer; Kristin Valdez; Maggie Cam; T Jake Liang
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

Review 10.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.